Robert F Kennedy Jr. Exposes Bill Gates’ Vaccine

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
324
Robert F Kennedy Jr. Exposes Bill Gates’ Vaccine Dictatorship Plan


Robert F Kennedy Jr. Exposes Bill Gates' Vaccine Dictatorship Plan - cites Gates' twisted 'Messiah Complex' - Fort Russ
Robert Francis Kennedy Jr. is an American environmental attorney, author, and opponent of vaccination. Kennedy is a son of Robert F. Kennedy and nephew of former president John F. Kennedy. He is the president of the board of Waterkeeper Alliance, a non-profit environmental group that he helped found in 1999.


https://www.patreon.com/posts/35844091?fbclid...KzAsZV2yFI

Does the whole pandemic stand to benefit Bill Gates tremendously as he will provide the technology to develop "global immunity passports" and the Gates Foundation will be heavily involved in any vaccine creation? Is it possible?

#Vaccines, for #BillGates, are a strategic philanthropy that feed his many vaccine-related businesses (including #Microsoft’s ambition to control a global vac ID enterprise) and give him dictatorial control over global health policy—the spear tip of corporate neo-imperialism.

Gates’ obsession with vaccines seems fueled by a messianic conviction that he is ordained to save the world with technology and a god-like willingness to experiment with the lives of lesser humans.

Promising to eradicate Polio with $1.2 billion, Gates took control of India ‘s National Advisory Board (NAB) and mandated 50 polio vaccines (up from 5) to every child before age 5. Indian doctors blame the Gates campaign for a devastating vaccine-strain polio epidemic that paralyzed 496,000 children between 2000 and 2017. In 2017, the Indian Government dialed back Gates’ vaccine regimen and evicted Gates and his cronies from the NAB. Polio paralysis rates dropped precipitously. In 2017, the World Health Organization reluctantly admitted that the global polio explosion is predominantly vaccine strain, meaning it is coming from Gates’ Vaccine Program. The most frightening epidemics in Congo, the Philippines, and Afghanistan are all linked to Gates’ vaccines. By 2018, ¾ of global polio cases were from Gates’ vaccines.

In 2014, the #GatesFoundation funded tests of experimental HPV vaccines, developed by GSK and Merck, on 23,000 young girls in remote Indian provinces. Approximately 1,200 suffered severe side effects, including autoimmune and fertility disorders. Seven died. Indian government investigations charged that Gates funded researchers committed pervasive ethical violations: pressuring vulnerable village girls into the trial, bullying parents, forging consent forms, and refusing medical care to the injured girls. The case is now in the country’s Supreme Court.

In 2010, the Gates Foundation funded a trial of a GSK’s experimental malaria vaccine, killing 151 African infants and causing serious adverse effects including paralysis, seizure, and febrile convulsions to 1,048 of the 5,049 children.

During Gates 2002 MenAfriVac Campaign in Sub-Saharan Africa, Gates operatives forcibly vaccinated thousands of African children against meningitis. Between 50-500 children developed paralysis. South African newspapers complained, “We are guinea pigs for drug makers”

Nelson Mandela’s former Senior Economist, Professor Patrick Bond, describes Gates’ philantropic practices as “ruthless” and “immoral”.

In 2010, Gates committed $10 billion to the WHO promising to reduce population, in part, through new vaccines. A month later Gates told a Ted Talk that new vaccines “could reduce population”. In 2014, Kenya’s Catholic Doctors Association accused the WHO of chemically sterilizing millions of unwilling Kenyan women with a phony “tetanus” vaccine campaign.

Independent labs found the sterility formula in every vaccine tested.

After denying the charges, WHO finally admitted it had been developing the sterility vaccines for over a decade.

Similar accusations came from Tanzania, Nicaragua, Mexico and the Philippines.

A 2017 study (Morgensen et.Al.2017) showed that WHO’s popular DTP is killing more African than the disease it pretends to prevent. Vaccinated girls suffered 10x the death rate of unvaccinated children.

Gates and the WHO refused to recall the lethal vaccine which WHO forces upon millions of African children annually.

Global public health advocates around the world accuse Gates of – hijacking WHO’s agenda away from the projects that are proven to curb infectious diseases; clean water, hygiene, nutrition and economic development.

They say he has diverted agency resources to serve his personal fetish – that good health only comes in a syringe.

In addition to using his philanthropy to control WHO, UNICEF, GAVI and PATH, Gates funds private pharmaceutical companies that manufacture vaccines, and a massive network of pharmaceutical industry front groups that broadcast deceptive propaganda, develop fraudulent studies, conduct surveillance and psychological operations against vaccine hesitancy and use Gates’ power and money to silence dissent and coerce compliance.
In this recent nonstop Pharmedia appearances, Gates appears gleeful that the Covid-19 crisis will give him the opportunity to force his third-world vaccine programs on American children.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 5

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 17

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 10

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 7

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 5

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 8

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 8

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 5

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 6

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 9

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading

Top 5 Most Recently Viewed Articles

Globavend Holdings Faces Major Share Price Decline Post Split

Updated Category News Views 322

Significant Decline in Globavend Holdings Shares Shares of Globavend Holdings Limited (NASDAQ: GVH) are experiencing a substantial downturn as investors react to the recent announcement of a 1-for-200 reverse stock split. This financial maneuver aims to consolidate outstanding shares, however, it is being interpreted by many as a signal of potential financial instability....

Continue Reading
Motto Mortgage Expands Reach with New Franchise Office

Updated Category News Views 329

Motto Mortgage Expands with New Franchise Office Motto Mortgage, a pioneering name in the mortgage brokerage sector, has added a new franchise to its growing network. This new office is meticulously led by a dedicated team of experienced professionals, aiming to provide homebuyers and those seeking refinancing solutions with competitive rates and profound knowledge about...

Continue Reading
Village Farms International Set to Shine at Cannabis Conference

Updated Category News Views 150

Panel Discussions That Pack a Punch The company’s heavy hitters aren’t just attending—they’re taking center stage. Michael DeGiglio, President and CEO, will grace a panel titled Europe, Australia, Southeast Asia…Canada? Where is the Real Cash Cow. Scheduled for 3 PM on October 8, this discussion aims to dissect global markets for cannabis while hunting for those...

Continue Reading
Profound Medical Corp. Unveils Key Financial Insights Soon

Updated Category News Views 92

Profound Medical Set to Release Third Quarter Financial Results Profound Medical Corp. (NASDAQ: PROF; TSX: PRN), a leading medical device company specializing in innovative, incision-free therapies for treating disease, is gearing up to deliver its financial results for the third quarter of 2024. Investors and stakeholders will be eagerly awaiting the insights that come...

Continue Reading
Steelcase's Third Quarter Update: Strong Revenue Growth Insights

Updated Category News Views 100

Steelcase Inc. Reports Third Quarter Earnings Steelcase Inc. recently announced its earnings for the third quarter of fiscal year 2025, revealing significant growth metrics and updates on future prospects. The company reported revenue of $794.9 million, which reflects a 2% increase compared to the same quarter last year when it earned $777.9 million. This revenue growth...

Continue Reading